Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2021
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASHAmalia Gastaldelli, Silvia Sabatini, Fabrizia Carli, et al.
The Journal of Biological Chemistry|December 16, 2004
Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscleDawn K Richardson, Sangeeta Kashyap, Mandeep Bajaj, et al.
Hepatology (Baltimore, Md.)|December 21, 2011
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver diseaseRomina Lomonaco, Carolina Ortiz-Lopez, Beverly Orsak, et al.
Obesity (Silver Spring, Md.)|April 27, 2022
Greater ectopic fat deposition and liver fibroinflammation and lower skeletal muscle mass in people with type 2 diabetesTom Waddell, Alexandre Bagur, Diogo Cunha, et al.
Gastroenterology|August 8, 2007
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjectsAmalia Gastaldelli, Kenneth Cusi, Maura Pettiti, et al.
Hepatology (Baltimore, Md.)|December 17, 2016
Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver diseaseFernando Bril, Diana Barb, Paola Portillo-Sanchez, et al.
Journal of Clinical Gastroenterology|October 17, 2022
Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic SteatohepatitisIra M Jacobson, Vincent Wai-Sun Wong, Laurent Castera, et al.
Diabetes, Obesity & Metabolism|March 13, 2018
Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitusFernando Bril, Laura Millán, Srilaxmi Kalavalapalli, et al.
Pageof 19